Genetic testing to identify hereditary predispositions to haematological malignancy is critical prior to allogenic haematopoietic cell transplant

Affiliations

• ¹ Oncogenesis and Development Section, Translational and Functional Genomics Branch (TFGB), National Human Genome Research Institute (NHGRI), Bethesda, Maryland, USA.
• ² Genetics Branch, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, Maryland, USA.
• ³ Translational Stem Cell Biology Branch, National Heart Lung, and Blood Institute (NHLBI), Bethesda, Maryland, USA.
• ⁴ Center for Immuno-Oncology, Center for Cancer Research, NCI, Bethesda, Maryland, USA.
• ⁵ Immune-Deficiency Cellular Therapy Program, Center for Cancer Research, NCI, Bethesda, Maryland, USA.